Asia Pacific Pharmaceutical Drug Delivery Market Drivers and Forecasts by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

Asia Pacific Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country

Report Date : Jun 2020
Report Code : TIPRE00011593

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 146

Page Updated: Jun 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The Asia Pacific pharmaceutical drug delivery market is anticipated to reach US$ 473,700.1 Mn by 2027 from US$ 277,589.9 Mn in 2019. The market is projected to grow at a CAGR of 7.1% from 2020 to 2027.

The pharmaceutical drug delivery market in this region is growing primarily due to the increasing shortage of medicines. However, the low availability of R&D funding by government in developing economies limits the growth of the market in Asia Pacific. On the other hand, growing emerging markets is expected to have a positive impact on the growth of the Asia Pacific pharmaceutical drug delivery market in the coming years.

Countries in Asia Pacific are emerging as attractive outsourcing locations for pharmaceutical industries. Low manufacturing and operating costs is the key factor that driving the growth of pharmaceutical industry in China and India, among others. Recent growth in the pharmaceuticals in both these countries indicate positive future outlook of the market players. Also, the growing domestic market and ongoing innovations in the drug delivery system are further opening new avenues for the pharmaceutical drug delivery players in APAC.

In 2019, China accounted for the largest share of the Asia Pacific pharmaceutical drug delivery market, and it is also expected to grow at a faster pace over the forecast period. The growing research activities in pharmaceutical drug delivery technologies and significant prevalence of disease are the key factors supporting the growth of the market in this country. Moreover, many markets players are focusing on geographic expansion in China.

China Pharmaceutical Drug Delivery Market, Revenue and Forecast to 2027 (US$ Mn)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

ASIA PACIFIC PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION

By Route of Administration

Oral Drug Delivery
Injectable Drug Delivery
Topical Drug Delivery
Ocular Drug Delivery
Pulmonary Drug Delivery
Nasal Drug Delivery
Transmucosal Drug Delivery
Implantable Drug Delivery

By Application

Infectious Diseases
Cancer
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Central Nervous System Disorders
Autoimmune Diseases
Other Applications

By End User

Hospitals
Home Care Settings
ASC/Clinics
Other End Users

By Country

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea

Company Profiles

3M
Antares Pharma
Bayer AG
BD
GlaxoSmithKline plc

Asia Pacific Pharmaceutical Drug Delivery Report Scope

Report Attribute	Details
Market size in 2019	US$ 277,589.9 Million
Market Size by 2027	US$ 473,700.1 Million
Global CAGR (2020 - 2027)	7.1%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Route of Administration Oral Drug Delivery Injectable Drug Delivery Topical Drug Delivery Ocular Drug Delivery Pulmonary Drug Delivery Nasal Drug Delivery Transmucosal Drug Delivery Implantable Drug Delivery By Application Infectious Diseases Cancer Cardiovascular Diseases Diabetes Respiratory. Diseases Central Nervous System Disorders Autoimmune Diseases Other Diseases By End User Hospitals Home Care Settings ASC/Clinics Other End Users
Regions and Countries Covered	Asia-Pacific China India Japan Australia Rest of Asia-Pacific
Market leaders and key company profiles	3M Antares Pharma Bayer AG BD GlaxoSmithKline plc

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Asia Pacific Pharmaceutical Drug Delivery Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy